J.M. Forbes & Co’s AbbVie ABBV Stock Holding History

J.M. Forbes & Co’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.64M	Buy	14,460 +16	+0.1%	+$3.44K	0.29%	62
2026 Q1	$3.14M	Buy	14,444 +1,012	+8%	+$224K	0.27%	62
2025 Q4	$3.07M	Sell	13,432 -203	-1%	-$46.2K	0.25%	62
2025 Q3	$3.16M	Buy	13,635 +417	+3%	+$84.9K	0.26%	63
2025 Q2	$2.45M	Sell	13,218 -838	-6%	-$156K	0.22%	65
2025 Q1	$2.95M	Sell	14,056 -173	-1%	-$33.6K	0.29%	63
2024 Q4	$2.53M	Sell	14,229 -116	-0.8%	-$21.3K	0.24%	65
2024 Q3	$2.83M	Hold	14,345	–	–	0.28%	61
2024 Q2	$2.46M	Buy	14,345 +71	+0.5%	+$11.8K	0.25%	62
2024 Q1	$2.6M	Hold	14,274	–	–	0.28%	60
2023 Q4	$2.21M	Sell	14,274 -73	-0.5%	-$10.6K	0.26%	63
2023 Q3	$2.14M	Buy	14,347 +300	+2%	+$44K	0.28%	61
2023 Q2	$1.89M	Buy	14,047 +7,149	+104%	+$1.05M	0.24%	63
2023 Q1	$1.1M	Sell	6,898 -1,276	-16%	-$195K	0.15%	51
2022 Q4	$1.32M	Buy	8,174 +133	+2%	+$20.4K	0.19%	48
2022 Q3	$1.08M	Hold	8,041	–	–	0.17%	52
2022 Q2	$1.23M	Hold	8,041	–	–	0.18%	51
2022 Q1	$1.3M	Hold	8,041	–	–	0.16%	54
2021 Q4	$1.09M	Sell	8,041 -141	-2%	-$16.7K	0.13%	58
2021 Q3	$883K	Sell	8,182 -345	-4%	-$39.4K	0.11%	60
2021 Q2	$960K	Hold	8,527	–	–	0.12%	58
2021 Q1	$923K	Hold	8,527	–	–	0.13%	51
2020 Q4	$914K	Buy	8,527 +400	+5%	+$38.4K	0.13%	47
2020 Q3	$715K	Buy	8,127 +1,990	+32%	+$187K	0.11%	58
2020 Q2	$603K	Hold	6,137	–	–	0.11%	58
2020 Q1	$468K	Sell	6,137 -55	-0.9%	-$4.68K	0.1%	60
2019 Q4	$548K	Sell	6,192 -130	-2%	-$10.8K	0.09%	71
2019 Q3	$479K	Hold	6,322	–	–	0.09%	73
2019 Q2	$460K	Sell	6,322 -65	-1%	-$5.11K	0.09%	70
2019 Q1	$515K	Sell	6,387 -378	-6%	-$30.9K	0.11%	67
2018 Q4	$624K	Hold	6,765	–	–	0.15%	58
2018 Q3	$640K	Sell	6,765 -91,619	-93%	-$8.69M	0.14%	64
2018 Q2	$9.12M	Buy	98,384 +149	+0.2%	+$14.6K	2.04%	21
2018 Q1	$9.3M	Buy	98,235 +1,070	+1%	+$118K	2.17%	17
2017 Q4	$9.4M	Buy	97,165 +2,038	+2%	+$192K	2.17%	17
2017 Q3	$8.45M	Sell	95,127 -1,141	-1%	-$86.9K	2.11%	20
2017 Q2	$6.98M	Sell	96,268 -556	-0.6%	-$37.4K	1.78%	27
2017 Q1	$6.31M	Sell	96,824 -684	-0.7%	-$43K	1.65%	32
2016 Q4	$6.11M	Buy	97,508 +460	+0.5%	+$28.1K	1.68%	30
2016 Q3	$6.12M	Sell	97,048 -1,087	-1%	-$70.4K	1.67%	29
2016 Q2	$6.08M	Buy	98,135 +683	+0.7%	+$41.6K	1.68%	30
2016 Q1	$5.57M	Buy	97,452 +1,080	+1%	+$60.2K	1.59%	34
2015 Q4	$5.71M	Sell	96,372 -635	-0.7%	-$36.6K	1.53%	34
2015 Q3	$5.28M	Sell	97,007 -47,560	-33%	-$3.1M	1.5%	34
2015 Q2	$9.71M	Sell	144,567 -2,810	-2%	-$183K	2.62%	12
2015 Q1	$8.63M	Sell	147,377 -3,088	-2%	-$187K	2.29%	17
2014 Q4	$8.56M	Buy	150,465 +81,056	+117%	+$5.11M	2.24%	18
2014 Q3	$4.01M	Sell	69,409 -277	-0.4%	-$15.4K	1.01%	43
2014 Q2	$3.93M	Sell	69,686 -776	-1%	-$40.7K	0.98%	42
2014 Q1	$3.62M	Sell	70,462 -1,249	-2%	-$63.1K	0.94%	42
2013 Q4	$3.79M	Buy	71,711 +2,638	+4%	+$130K	0.96%	44
2013 Q3	$3.09M	Buy	69,073 +719	+1%	+$31.9K	0.87%	47
2013 Q2	$2.83M	Buy	+68,354	New	+$2.99M	0.84%	46

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

J.M. Forbes & Co's ABBV Position: Q2 2026 in Review

J.M. Forbes & Co increased its AbbVie (ABBV) stake by 0.11% in Q2 2026, buying an estimated $3.44K and bringing the position to 14,460 shares worth $3.64M. The position accounts for 0.29% of the portfolio, ranked #62.

J.M. Forbes & Co first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.71M in Q2 2015. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

J.M. Forbes & Co held 14,460 shares of AbbVie worth $3.64M as of Q2 2026.
J.M. Forbes & Co bought 16 AbbVie shares in Q2 2026, an estimated $3.44K.
AbbVie made up 0.29% of J.M. Forbes & Co's portfolio in Q2 2026, its #62 holding.
J.M. Forbes & Co first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
J.M. Forbes & Co's AbbVie position peaked at $9.71M in Q2 2015.
4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on J.M. Forbes & Co's 13F filing for Q2 2026, filed 20 Jul 2026.